Bundle 04
If you are seeing this page, then you are not signed or have not yet enrolled in the City of Hope/VA Cancer Genomics in Practice course. To begin your enrollment, return to the homepage by clicking the button below, then sign in and click the yellow "ENROLL" button at the top right of the page.
If you need assistance, contact us at CGEP@coh.org.
|
Instruction |
|
Time |
|
Tasks |
➤ Bundle 04 Learner Notification
➤ Bundles 01-10 Learner Notification for ABIM MOC (pending)
Tumor/Germline Analysis in GCRA Practice
- Review the considerations across germline, somatic, and paired testing
- Recognize confounding or incidental phenomena that can be captured on testing
- Discuss how genomic data is changing treatment paradigms and implications for actionability/management
- Discuss ongoing patient, provider, and system-level challenges to genomic test integration
Pharmacogenomics in Cancer Care: What you need to know
- Describe the Principles of Pharmacogenomics (PGx)
- Identify Clinical Applications in oncology care and clinical utility of PGx
- Apply principles of oncology pharmacogenomics to a patient case
Padma Sheila Rajagopal, MD, MPH, MSc
Physician-Scientist Early Investigator
Cancer Data Science Laboratory and Women's Malignancies Branch at the National Cancer Institute
Dr. Padma Sheila Rajagopal received her M.D. at Columbia University’s College of Physicians and Surgeons, during which she also received an M.P.H. in quantitative methods with a focus on genetic epidemiology at the Harvard School of Public Health. She completed her internal medicine residency training at the University of Pittsburgh and a fellowship in hematology/oncology with an additional fellowship year focused on cancer genetics at the University of Chicago, where she received an M.Sc. in biomedical informatics. Dr. Rajagopal is a recipient of the Ruth L. Kirschstein F32 Postdoctoral Fellowship and the American Society of Clinical Oncology / Breast Cancer Research Foundation Conquer Cancer Young Investigator Award.
Dr. Rajagopal’s laboratory focuses on how characterizing genomic and transcriptomic interactions between germline variants / inherited cancer syndromes and somatic development in tumors can improve clinical prediction and prognostication in patients with cancer. Her current research focuses on using transcriptomics to characterize breast cancers and treatment responses in patients with hereditary cancer syndromes.
Jill Bates, PharmD, MS, BCOP, CPT, FASHP
Deputy Executive Director of the National Pharmacogenomics Program
Department of Veterans Affairs
Dr. Bates is the Deputy Executive Director of the National Pharmacogenomics Program for the Department of Veterans Affairs, specializing in precision medicine. She is also Associate Professor of Clinical Education at the UNC Eshelman School of Pharmacy. Dr. Bates completed her Bachelor of Science at Eastern Illinois University, a Master of Science with concentration in biochemistry and biophysics at Northern Illinois University and her Doctor of Pharmacy at the University of Illinois at Chicago. She completed a post graduate year 1 (PGY1) pharmacy practice and PGY2 oncology pharmacy residency at Duke University Medical Center and is certified in both pharmacogenomics and precision oncology. Dr. Bates has experience as a leader in clinical pharmacy practice, oncology pharmacy, and residency training. She has a passion for advancing pharmacy practice through education rooted in the belief that learning improves lives. Dr. Bates was recognized for her achievements when she was selected as the inaugural recipient of the Milton W Skolaut leadership award bestowed by Duke University Medical Center, designated as Fellow by ASHP, and awarded the Distinguished Service Award in 2019 by the American Society of Health System Pharmacists Section of Clinical Specialists and Scientists.